Saturday, March 26, 2022

< + > Pfizer Recalling 3 Blood Pressure Medication Types Due To Cancer Concerns, FDA Says

This time the culprit is a nitrosamine, N-nitroso-quinapril, being present in quantities above Acceptable Daily Intake (ADI) levels.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Bonus Features – November 1, 2026 – 91% of patients want their permission required when AI is used for diagnosis, 64% of providers plan to deploy AI for claims and denials management, plus 20 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...